HCA Healthcare, Inc. $HCA Stock Holdings Lowered by Robeco Institutional Asset Management B.V.

Posted by Brian Himes on Oct 25th, 2026

Robeco Institutional Asset Management B.V. decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 26.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,727 shares of the company’s stock after selling 5,686 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in HCA Healthcare were worth $6,711,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in HCA. BlackRock Inc. purchased a new stake in shares of HCA Healthcare in the second quarter worth $5,069,974,000. Wellington Management Group LLP boosted its stake in HCA Healthcare by 20.5% in the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after purchasing an additional 799,761 shares in the last quarter. Darsana Capital Partners LP grew its holdings in shares of HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after buying an additional 350,000 shares during the last quarter. Legal & General Group Plc bought a new stake in shares of HCA Healthcare in the 2nd quarter worth $410,992,000. Finally, Jupiter Topco LLC bought a new position in HCA Healthcare during the 2nd quarter valued at about $371,138,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

Positive Sentiment: Attractive valuation: Zacks identifies HCA as a strong value stock, which may appeal to investors seeking a relatively inexpensive healthcare company with potential for market-beating returns. Here’s Why HCA Healthcare Is a Strong Value Stock
Positive Sentiment: Defensive investor interest: A broader rotation toward high-quality, defensive companies in healthcare and other essential sectors could provide a supportive backdrop for HCA stock. Defensive Rotation Toward Quality Companies
Positive Sentiment: Expansion in Florida: Cape Coral approved $31 million in incentives for a planned $300 million HCA hospital, supporting the company’s long-term market expansion and future capacity. Cape Coral Approves Incentives for HCA Hospital
Neutral Sentiment: Upcoming earnings catalyst: HCA is scheduled to report third-quarter results around October 27. Investors are focused on admissions, occupancy, inpatient revenue and other operating metrics, with the report likely to determine the stock’s next significant move. HCA Third-Quarter Earnings Preview
Neutral Sentiment: Workforce investment: HCA opened a clinical training center in Gainesville, which may strengthen its healthcare staffing pipeline but is unlikely to materially affect near-term earnings. HCA Opens Clinical Training Center
Negative Sentiment: Mixed earnings outlook: Higher admissions, occupancy and inpatient revenue could help third-quarter results, but rising costs and fewer outpatient surgeries may pressure margins and temper investor expectations. Will HCA Earnings Benefit From Higher Admissions?

HCA Healthcare Trading Up 0.5%

NYSE:HCA opened at $469.45 on Friday. The firm has a fifty day simple moving average of $431.58 and a 200-day simple moving average of $418.97. The company has a market capitalization of $101.64 billion, a P/E ratio of 15.72, a PEG ratio of 1.58 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the company posted $6.84 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. Equities analysts forecast that HCA Healthcare, Inc. will post 29.51 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently commented on the company. Mizuho reduced their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. Wells Fargo & Company lifted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. TD Cowen raised their price target on HCA Healthcare from $431.00 to $460.00 and gave the company a “buy” rating in a report on Monday, October 12th. Oppenheimer lowered their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Finally, Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $467.61.

Get Our Latest Research Report on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.